Your browser doesn't support javascript.
loading
Rituximab as first-line treatment for the management of adult patients with non-severe hemophilia A and inhibitors.
Lim, M Y; Nielsen, B; Lee, K; Kasthuri, R S; Key, N S; Ma, A D.
Affiliation
  • Lim MY; Department of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC, USA.
J Thromb Haemost ; 12(6): 897-901, 2014 Jun.
Article in En | MEDLINE | ID: mdl-24702722
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor VIII / Coagulants / Antibodies, Monoclonal, Murine-Derived / Hemophilia A / Immunosuppressive Agents / Antibodies Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2014 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor VIII / Coagulants / Antibodies, Monoclonal, Murine-Derived / Hemophilia A / Immunosuppressive Agents / Antibodies Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2014 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido